Kadimastem has Upgraded its Manufacturing Site for Treatment of ALS Patients in the Clinical Trial
- sherzl
- Jul 1, 2018
- 1 min read
Kadimastem chose to upgrade the production rooms, for the treatment of ALS patients in the Phase 1 / 2a clinical trial, and adapt them to the stringent European production standards. The production area conforms to the Grade B level GMP (Good Manufacturing Practices) standards, with the actual production being carried out in GMP Grade A level biological hoods. The upgraded rooms have successfully undergone validation and quality assurance certifications. The production process was tested and validated and was approved by the Ministry of Health, thus completing the company's preparation for the production of the AstroRx® clinical product at a very high quality standard.
The clinical trial is being conducted in the Department of Neurology of the Hadassah Ein-Kerem Medical Center, and interim results are expected within the coming year.
I was diagnosed with ALS four years ago. For over two years, I relied on prescription medications and therapies, but unfortunately, the symptoms continued to worsen. My mobility declined, muscle weakness increased, and I experienced growing fatigue and discomfort that affected my daily life.Last year, out of desperation and hope, I decided to try an herbal treatment program from NaturePath Herbal Clinic. Honestly, I was skeptical at first, but within a few months of starting the treatment, I began to notice real changes. My energy improved, the discomfort eased, and I felt stronger and more capable in my daily life.Incredibly, I also regained much of my stamina, balance, and confidence. It has truly been a life-changing experience I feel more…